These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


232 related items for PubMed ID: 16687990

  • 1. Pharmacotherapy for disordered sleep in post-traumatic stress disorder: a systematic review.
    van Liempt S, Vermetten E, Geuze E, Westenberg HG.
    Int Clin Psychopharmacol; 2006 Jul; 21(4):193-202. PubMed ID: 16687990
    [Abstract] [Full Text] [Related]

  • 2. Sleep disturbances in patients with post-traumatic stress disorder: epidemiology, impact and approaches to management.
    Maher MJ, Rego SA, Asnis GM.
    CNS Drugs; 2006 Jul; 20(7):567-90. PubMed ID: 16800716
    [Abstract] [Full Text] [Related]

  • 3. Pharmacotherapy of post-traumatic stress disorder.
    Ravindran LN, Stein MB.
    Curr Top Behav Neurosci; 2010 Jul; 2():505-25. PubMed ID: 21309124
    [Abstract] [Full Text] [Related]

  • 4. SSRIs versus non-SSRIs in post-traumatic stress disorder: an update with recommendations.
    Asnis GM, Kohn SR, Henderson M, Brown NL.
    Drugs; 2004 Jul; 64(4):383-404. PubMed ID: 14969574
    [Abstract] [Full Text] [Related]

  • 5. [Treatment-resistant anxiety disorders: A literature review of drug therapy strategies].
    Ammar G, Naja WJ, Pelissolo A.
    Encephale; 2015 Jun; 41(3):260-5. PubMed ID: 25439852
    [Abstract] [Full Text] [Related]

  • 6. The Psychopharmacology Algorithm Project at the Harvard South Shore Program: an update on posttraumatic stress disorder.
    Bajor LA, Ticlea AN, Osser DN.
    Harv Rev Psychiatry; 2011 Jun; 19(5):240-58. PubMed ID: 21916826
    [Abstract] [Full Text] [Related]

  • 7. Prazosin in Children and Adolescents With Posttraumatic Stress Disorder Who Have Nightmares: A Systematic Review.
    Akinsanya A, Marwaha R, Tampi RR.
    J Clin Psychopharmacol; 2017 Feb; 37(1):84-88. PubMed ID: 27930498
    [Abstract] [Full Text] [Related]

  • 8. Pharmacotherapy for post-traumatic stress disorder: a comprehensive review.
    Davis LL, English BA, Ambrose SM, Petty F.
    Expert Opin Pharmacother; 2001 Oct; 2(10):1583-95. PubMed ID: 11825301
    [Abstract] [Full Text] [Related]

  • 9. Pharmacotherapeutic treatment of nightmares and insomnia in posttraumatic stress disorder: an overview of the literature.
    van Liempt S, Vermetten E, Geuze E, Westenberg H.
    Ann N Y Acad Sci; 2006 Jul; 1071():502-7. PubMed ID: 16891608
    [Abstract] [Full Text] [Related]

  • 10. Pharmacologic alternatives to antidepressants in posttraumatic stress disorder: a systematic review.
    Berger W, Mendlowicz MV, Marques-Portella C, Kinrys G, Fontenelle LF, Marmar CR, Figueira I.
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar 17; 33(2):169-80. PubMed ID: 19141307
    [Abstract] [Full Text] [Related]

  • 11. Pharmacotherapy in post-traumatic stress disorder: evidence from randomized controlled trials.
    Sullivan GM, Neria Y.
    Curr Opin Investig Drugs; 2009 Jan 17; 10(1):35-45. PubMed ID: 19127485
    [Abstract] [Full Text] [Related]

  • 12. [Antipsychotics, anticonvulsants, antiadrenergics and other drugs: what to do when posttraumatic stress disorder does not respond to selective serotonin reuptake inhibitors?].
    Berger W, Portella CM, Fontenelle LF, Kinrys G, Mendlowicz MV.
    Braz J Psychiatry; 2007 Oct 17; 29 Suppl 2():S61-5. PubMed ID: 18157435
    [Abstract] [Full Text] [Related]

  • 13. Prazosin for treatment of nightmares related to posttraumatic stress disorder.
    Taylor HR, Freeman MK, Cates ME.
    Am J Health Syst Pharm; 2008 Apr 15; 65(8):716-22. PubMed ID: 18387899
    [Abstract] [Full Text] [Related]

  • 14. Prazosin for treating sleep disturbances in adults with posttraumatic stress disorder: a systematic review and meta-analysis of randomized controlled trials.
    Khachatryan D, Groll D, Booij L, Sepehry AA, Schütz CG.
    Gen Hosp Psychiatry; 2016 Apr 15; 39():46-52. PubMed ID: 26644317
    [Abstract] [Full Text] [Related]

  • 15. Treatment of nightmares with prazosin: a systematic review.
    Kung S, Espinel Z, Lapid MI.
    Mayo Clin Proc; 2012 Sep 15; 87(9):890-900. PubMed ID: 22883741
    [Abstract] [Full Text] [Related]

  • 16. The effects of prazosin on sleep disturbances in post-traumatic stress disorder: a systematic review and meta-analysis.
    Zhang Y, Ren R, Sanford LD, Yang L, Ni Y, Zhou J, Zhang J, Wing YK, Shi J, Lu L, Tang X.
    Sleep Med; 2020 Mar 15; 67():225-231. PubMed ID: 31972510
    [Abstract] [Full Text] [Related]

  • 17. Targeting the Noradrenergic System in Posttraumatic Stress Disorder: A Systematic Review and Meta-Analysis of Prazosin Trials.
    De Berardis D, Marini S, Serroni N, Iasevoli F, Tomasetti C, de Bartolomeis A, Mazza M, Tempesta D, Valchera A, Fornaro M, Pompili M, Sepede G, Vellante F, Orsolini L, Martinotti G, Di Giannantonio M.
    Curr Drug Targets; 2015 Mar 15; 16(10):1094-106. PubMed ID: 25944011
    [Abstract] [Full Text] [Related]

  • 18. Pharmacology for sleep disturbance in PTSD.
    Lipinska G, Baldwin DS, Thomas KG.
    Hum Psychopharmacol; 2016 Mar 15; 31(2):156-63. PubMed ID: 26856810
    [Abstract] [Full Text] [Related]

  • 19. Biological therapies for posttraumatic stress disorder: an overview.
    Davidson JR.
    J Clin Psychiatry; 1997 Mar 15; 58 Suppl 9():29-32. PubMed ID: 9329449
    [Abstract] [Full Text] [Related]

  • 20. Post-traumatic stress disorder: an evaluation of existing pharmacotherapies and new strategies.
    Zhang W, Davidson JR.
    Expert Opin Pharmacother; 2007 Aug 15; 8(12):1861-70. PubMed ID: 17696789
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.